Microbial Ecology

, Volume 56, Issue 3, pp 395–402 | Cite as

Effect of Antibiotic Therapy on Human Fecal Microbiota and the Relation to the Development of Clostridium difficile

  • M. F. De La Cochetière
  • T. Durand
  • V. Lalande
  • J. C. Petit
  • G. Potel
  • L. Beaugerie
Original Article

Abstract

The gastrointestinal tract is a complex ecosystem. Recent studies have shown that the human fecal microbiota is composed of a consortium of microorganism. It is known that antibiotic treatment alters the microbiota, facilitating the proliferation of opportunists that may occupy ecological niches previously unavailable to them. It is therefore important to characterize resident microbiota to evaluate its latent ability to permit the development of pathogens such as Clostridium difficile. Using samples from 260 subjects enrolled in a previously published clinical study on antibiotic-associated diarrhea, we investigated the possible relationship between the fecal dominant resident microbiota and the subsequent development of C. difficile. We used molecular profiling of bacterial 16S rDNA coupled with partial least square (PLS) regression analysis. Fecal samples were collected on day 0 (D0) before antibiotic treatment and on day 14 (D14) after the beginning of the treatment. Fecal DNA was isolated, and V6-to-V8 regions of the 16S rDNA were amplified by polymerase chain reaction with general primers and analyzed by temporal temperature gradient gel electrophoresis (TTGE). Main bacteria profiles were compared on the basis of similarity (Pearson correlation coefficient). The characteristics of the microbiota were determined using PLS discriminant analysis model. Eighty-seven TTGE profiles on D0 have been analyzed. The banding pattern was complex in all cases. The subsequent onset of C. difficile was not revealed by any clustering of TTGE profiles, but was explained up to 46% by the corresponding PLS model. Furthermore, 6 zones out of the 438 dispatched from the TTGE profiles by the software happened to be specific for the group of patients who acquired C. difficile. The first approach in the molecular phylogenetic analysis showed related sequences to uncultured clones. As for the 87 TTGE profiles on D14, no clustering could be found either, but the subsequent onset of C. difficile was explained up to 74.5% by the corresponding PLS model, thus corroborating the results found on D0. The non exhaustive data of the microbiota we found should be taken as the first step to assess the hypothesis of permissive microbiota. The PLS model was used successfully to predict C. difficile development. We found that important criteria in terms of main bacteria could be markedly considered as predisposing factors for C. difficile development. Yet, the resident microbiota in case of antibiotic-associated diarrhea has still to be analyzed. Furthermore, these findings suggest that strategies reinforcing the ability of the fecal microbiota to resist to modifications would be of clinical relevance.

References

  1. 1.
    Bartosch S, Fite A, Macfarlane GT, McMurdo ME (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70:3575–3581PubMedCrossRefGoogle Scholar
  2. 2.
    Beaugerie L, Flahault A, Barbut F, Atlan P, Lalande V, Cousin P, Cadilhac M, Petit JC (2003) Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 17:905–912PubMedCrossRefGoogle Scholar
  3. 3.
    Blaut M, Collins MD, Welling GW, Dore J, van Loo J, de Vos W (2002) Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr 87(Suppl 2):S203–211PubMedCrossRefGoogle Scholar
  4. 4.
    Borriello SP (1998) Pathogenesis of Clostridium difficile infection. J Antimicrob Chemother 41(Suppl C):13–19PubMedCrossRefGoogle Scholar
  5. 5.
    Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, Garcia P, Cai J, Hippe H, Farrow JA (1994) The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol 44:812–826PubMedCrossRefGoogle Scholar
  6. 6.
    De La Cochetiere MF, Durand T, Lepage P, Bourreille A, Galmiche JP, Dore J (2005) Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43:5588–5592CrossRefGoogle Scholar
  7. 7.
    De La Cochetiere MF, Piloquet H, des Robert C, Darmaun D, Galmiche JP, Roze JC (2004) Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr Res 56:366–370PubMedCrossRefGoogle Scholar
  8. 8.
    Eriksson L, Antti H, Gottfries J, Holmes E, Johansson E, Lindgren F, Long I, Lundstedt T, Trygg J, Wold S (2004) Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal Bioanal Chem 380:419–429PubMedCrossRefGoogle Scholar
  9. 9.
    Fromin N, Hamelin J, Tarnawski S, Roesti D, Jourdain-Miserez K, Forestier N, Teyssier-Cuvelle S, Gillet F, Aragno M, Rossi P (2002) Statistical analysis of denaturing gel electrophoresis (DGE) fingerprinting patterns. Environ Microbiol 4:634–643PubMedCrossRefGoogle Scholar
  10. 10.
    Godon JJ, Zumstein E, Dabert P, Habouzit F, Moletta R (1997) Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol 63:2802–2813PubMedGoogle Scholar
  11. 11.
    Hayashi H, Sakamoto M, Benno Y (2002) Fecal microbial diversity in a strict vegetarian as determined by molecular analysis and cultivation. Microbiol Immunol 46:819–831PubMedGoogle Scholar
  12. 12.
    Hayashi H, Sakamoto M, Benno Y (2002) Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 46:535–548PubMedGoogle Scholar
  13. 13.
    Huang XY, Chen JW, Gao LN, Ding GH, Zhao YZ, Schramm KW (2004) Data evaluations and quantitative predictive models for vapor pressures of polycyclic aromatic hydrocarbons at different temperatures. SAR QSAR Environ Res 15:115–125PubMedCrossRefGoogle Scholar
  14. 14.
    Lepage P, Seksik P, Sutren M, De La Cochetiere MF, Raymond J, Marteau P, Dore J (2005) Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 11:473–480PubMedCrossRefGoogle Scholar
  15. 15.
    Macfarlane GT, Macfarlane S (1997) Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 222:3–9PubMedGoogle Scholar
  16. 16.
    Marteau P, Lepage P, Mangin I, Suau A, Dore J, Pochart P, Seksik P (2004) Review article: gut flora and inflammatory bowel disease. Aliment Pharmacol Ther 20(Suppl 4):18–23PubMedCrossRefGoogle Scholar
  17. 17.
    Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R (2004) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70:7220–7228PubMedCrossRefGoogle Scholar
  18. 18.
    Matte-Tailliez O, Lepage E, Tenenhaus M, Tailliez P (2002) Use of predictive modeling for Propionibacterium strain classification. Syst Appl Microbiol 25:386–395PubMedCrossRefGoogle Scholar
  19. 19.
    McCracken VJ, Lorenz RG (2001) The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 3:1–11PubMedCrossRefGoogle Scholar
  20. 20.
    Morel E, Santamaria K, Perrier M, Guiot SR, Tartakovsky B (2004) Appliquation of multi-wavelength fluorometry for on-line monitoring of an anaerobic digestion process. Water Res 38:3287–3296PubMedCrossRefGoogle Scholar
  21. 21.
    Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R (2000) Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497–1500PubMedCrossRefGoogle Scholar
  22. 22.
    Ogier JC, Son O, Gruss A, Tailliez P, Delacroix-Buchet A (2002) Identification of the bacterial microflora in dairy products by temporal temperature gradient gel electrophoresis. Appl Environ Microbiol 68:3691–3701PubMedCrossRefGoogle Scholar
  23. 23.
    Rudi K, Maugesten T, Hannevik SE, Nissen H (2004) Explorative multivariate analyses of 16S rRNA gene data from microbial communities in modified-atmosphere-packed salmon and coalfish. Appl Environ Microbiol 70:5010–5018PubMedCrossRefGoogle Scholar
  24. 24.
    Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Dore J (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn’s disease of the colon. Gut 52:237–242PubMedCrossRefGoogle Scholar
  25. 25.
    Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65:4799–4807PubMedGoogle Scholar
  26. 26.
    Tannock GW (2002) Exploring the relationships between intestinal microflora and inflammatory conditions of the human bowel and spine. Antonie Van Leeuwenhoek 81:529–535PubMedCrossRefGoogle Scholar
  27. 27.
    Zoetendal EG, Akkermans AD, De Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64:3854–3859PubMedGoogle Scholar
  28. 28.
    Zoetendal EG, Ben-Amor K, Akkermans AD, Abee T, de Vos WM (2001) DNA isolation protocols affect the detection limit of PCR approaches of bacteria in samples from the human gastrointestinal tract. Syst Appl Microbiol 24:405–410PubMedCrossRefGoogle Scholar
  29. 29.
    Zoetendal EG, Cheng B, Koike S, Mackie RI (2004) Molecular microbial ecology of the gastrointestinal tract: from phylogeny to function. Curr Issues Intest Microbiol 5:31–47PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • M. F. De La Cochetière
    • 1
    • 3
  • T. Durand
    • 1
  • V. Lalande
    • 2
  • J. C. Petit
    • 2
  • G. Potel
    • 1
  • L. Beaugerie
    • 2
  1. 1.Thérapeutiques Cliniques et Expérimentales des Infections, EA 3826, UFR MédecineUniversité de Nantes, Nantes Atlantique UniversitésNantesFrance
  2. 2.Service de Gastro-entérologie et Nutrition, Hôpital Saint-AntoineParis CedexFrance
  3. 3.INSERMUPRES EA 3826, UFR de MédecineNantes, cedex 01France

Personalised recommendations